Clinical Trial Update: Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating reactogenicity, safety, and immunogenicity of an allantoic split inactivated seasonal influen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Human

Drugs mentioned

• Allantoic Split Inactivated Seasonal Influenza Vaccine

Snippet

Sponsor: Research Institute for Biological Safety Problems | Conditions: Influenza, Human | Phase 1 | Status: COMPLETED